Skip to main content
. 2007 May 11;133(9):599–611. doi: 10.1007/s00432-007-0206-0

Table 4.

The levels of sialyltransferase activities in human gastric carcinoma

Tissue specimen Sialyltransferase activity: incorporation of [9−3H]NeuAc(CPM × 10−3) catalyzed by 1 mg protein of the tissue extract
ST3(O) ST3(N) ST6(N)
NS7323 1.9 0.4 0
GC7323 326.8 ↑(172.0) 7.1 ↑(4.3) 0
NS7741 184.5 2.1 0.4
GC7741 53.8 ↓ (0.3) 3.1 ↑(1.5) 32.9 ↑(82.2)
NS7405 54.4 1.9 15.4
GC7405 145.1 ↑(2.7) 4.0 ↑(2.1) 8.3 ↓(0.5)
NS7570 234.2 1.1 16.2
GC7570 155.2 ↓(0.7) 1.6 ↑(1.5) 6.4 ↓(0.4)
NS9529 104.2 1.7 48.3
GC9529 240.3 ↑(2.3) 2.3 ↑(1.4) 11.9 ↓(0.2)
NS11681 306.5 2.6 8.3
GC11681 245.1 ↓(0.8) 2.2 ↓(0.8) 38.4 ↑(4.6)
NS11868 180.4 0.7 24.5
GC11868 309.0 ↑(1.7) 2.5 ↑(3.6) 25.2 ↑(1.0)
NS11954 15.6 0 0
GC11954 122.7 ↑(7.9) 0 7.3 ↑
NS11847 379.7 0.6 40.5
GC11847 83.3 ↓(0.5) 4.2 ↑(7.0) 65.0 ↑(1.6)
NS12015 148.6 3.6 50.1
GC12015 308.2 ↑(2.1) 3.8 ↑(1.1) 41.5 ↓(0.8)
GC7532 114.0 1.1 8.7
GC11577 91.9 2.7 8.2

Values in parentheses indicate the fold of enzyme activity in tumor specimen as compared to that of corresponding normal tissue of the patient

Acceptors used: ST3(O): 3-O-MeGalβ1,4GlcNAcβ1,6(Galβ1,3)GalNAcα-O-Bn; ST3(N): 2-O-MeGalβ1,3GlcNAcβ-O-Bn; ST6(N): the values obtained by using the acceptor Galβ1,4GlcNAcβ1,6(3-O-MeGalβ1,3)GalNAcα-O-Bn were corrected by subtracting the values obtained by using Galβ1,3GlcNAcβ-O-Bn, which is an acceptor for ST3(N) and also to some extent active with ST3(O)

NS Normal stomach, GC gastric carcinoma

↑ Increase, ↓ decrease